A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis
International Journal of Cancer, 04/19/2012
Campa D et al. – SNP rs717620 in ABCC2 was moderately associated with a poor response to chemotherapy but strongly with shorter progression free survival and overall survival in small cell lung carcinoma (SCLC) but not non–small cell lung carcinoma (NSCLC) patients, indicating that ABCC2 genetic variation is an important factor in SCLC survival after chemotherapy.



